Thromboembolism in patients with immune thrombocytopenia (ITP): a meta-analysis of observational studies

Risk of thromboembolism with thrombopoietin receptor agonists in adult patients with thrombocytopenia: Systematic review and meta-analysis of randomized controlled trials

(2015) Ferrán Catalá-López et al.   MEDICINA CLINICA

Thrombotic risk in patients with primary immune thrombocytopenia is only mildly increased and explained by personal and treatment-related risk factors

(2014) M. Ruggeri et al.   JOURNAL OF THROMBOSIS AND HAEMOSTASIS

Splenectomy and the incidence of venous thromboembolism and sepsis in patients with immune thrombocytopenia

(2013) S. Boyle et al.   BLOOD

Thrombotic risk in patients with immune thrombocytopenia and its association with antiphospholipid antibodies

(2013) Ki-Jo Kim et al.   BRITISH JOURNAL OF HAEMATOLOGY

Drug-Induced Thrombosis: An Update

(2013) Yuval Ramot et al.   DRUG SAFETY

Risk of arterial thrombosis in patients with primary chronic immune thrombocytopenia: a Danish population-based cohort study

(2012) Mette Nørgaard et al.   BRITISH JOURNAL OF HAEMATOLOGY

Thrombopoietin-receptor agonists

(2012) Paul A. Basciano et al.   CURRENT OPINION IN HEMATOLOGY

Thrombosis in patients with primary chronic immune thrombocytopenia

(2012) Mette Nørgaard   THROMBOSIS RESEARCH

The American Society of Hematology 2011 evidence-based practice guideline for immune thrombocytopenia

(2011) C. Neunert et al.   BLOOD

Newly diagnosed immune thrombocytopenia in children and adults: a comparative prospective observational registry of the Intercontinental Cooperative Immune Thrombocytopenia Study Group

(2011) T. Kuhne et al.   HAEMATOLOGICA

Risk of pulmonary embolism in patients with autoimmune disorders: a nationwide follow-up study from Sweden

(2011) Bengt Zöller et al.   LANCET

Cerebral sinus thrombosis following IV immunoglobulin therapy of immune thrombocytopenia purpura

(2011) Arwa Z. Al-Riyami et al.   PEDIATRIC BLOOD & CANCER

Clinical Implications of Elevated Antiphospholipid Antibodies in Adult Patients with Primary Immune Thrombocytopenia

(2011) Young-Joon Yang et al.   KOREAN JOURNAL OF INTERNAL MEDICINE

Risk of venous thromboembolism in patients with primary chronic immune thrombocytopenia: a Danish population-based cohort study

(2010) Marianne T. Severinsen et al.   BRITISH JOURNAL OF HAEMATOLOGY

Thromboembolic events among adult patients with primary immune thrombocytopenia in the United Kingdom General Practice Research Database

(2010) A. Sarpatwari et al.   HAEMATOLOGICA

Comorbidities in patients with persistent or chronic immune thrombocytopenia

(2010) Cheryl Enger et al.   INTERNATIONAL JOURNAL OF HEMATOLOGY

Risk of venous thromboembolism in splenectomized patients compared with the general population and appendectomized patients: a 10-year nationwide cohort study

(2010) R. W. THOMSEN et al.   JOURNAL OF THROMBOSIS AND HAEMOSTASIS

Vascular complications after splenectomy for hematologic disorders

(2009) S. E. Crary et al.   BLOOD

International consensus report on the investigation and management of primary immune thrombocytopenia

(2009) D. Provan et al.   BLOOD

The ITP syndrome: pathogenic and clinical diversity

(2009) D. B. Cines et al.   BLOOD

Effect of eltrombopag on platelet counts and bleeding during treatment of chronic idiopathic thrombocytopenic purpura: a randomised, double-blind, placebo-controlled trial

(2009) James B Bussel et al.   LANCET

Standardization of terminology, definitions and outcome criteria in immune thrombocytopenic purpura of adults and children: report from an international working group

(2008) F. Rodeghiero et al.   BLOOD

The Hematologic Manifestations of the Antiphospholipid Syndrome

(2008) Imad Uthman et al.   BLOOD REVIEWS

Antiphospholipid antibodies in adults with immune thrombocytopenic purpura

(2008) Carole Pierrot-Deseilligny Despujol et al.   BRITISH JOURNAL OF HAEMATOLOGY

Common risk factors for both arterial and venous thrombosis

(2008) Gordon D. O. Lowe   BRITISH JOURNAL OF HAEMATOLOGY

Efficacy of romiplostim in patients with chronic immune thrombocytopenic purpura: a double-blind randomised controlled trial

(2008) David J Kuter et al.   LANCET